Search Results - "Tasaki, Kazuto"
-
1
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer
Published in International journal of clinical oncology (01-04-2022)“…Purpose Platinum-resistant ovarian cancer (PROC) is usually treated with single-agent chemotherapy. A synergistic effect of gemcitabine and platinum has been…”
Get full text
Journal Article -
2
Carcinomatous meningitis from recurrent glassy cell carcinoma of the uterine cervix—A case report
Published in The journal of obstetrics and gynaecology research (01-09-2021)“…Carcinomatous meningitis presents with a variety of neurological symptoms and has a poor prognosis. We encountered a case of carcinomatous meningitis from…”
Get full text
Journal Article -
3
Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing
Published in The journal of obstetrics and gynaecology research (01-10-2021)“…Aim Type‐specific persistent infection (TSPI) of human papillomavirus (HPV) is reportedly associated with a high risk of residual/recurrent disease after local…”
Get full text
Journal Article -
4
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer
Published in Cancer science (01-11-2017)“…This phase 1, open‐label, dose‐escalation study was conducted to determine the safety, tolerability, pharmacokinetics and preliminary efficacy of veliparib…”
Get full text
Journal Article -
5
Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women
Published in Kurume medical journal (31-12-2022)“…Gastric-type mucinous carcinoma (GAS) of the uterine cervix is the most common adenocarcinoma that develops independently of human papillomavirus infection; it…”
Get more information
Journal Article -
6
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
Published in Journal of gynecologic oncology (01-11-2019)“…We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its…”
Get full text
Journal Article -
7
Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
Published in Journal of gynecologic oncology (01-09-2016)“…To identify key factors for predicting positive cone margin and appropriate cone length. We retrospectively reviewed the margin status of patients who received…”
Get full text
Journal Article -
8
Epithelial borderline ovarian tumor: Diagnosis and treatment strategy
Published in Obstetrics & gynecology science (01-05-2015)“…Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there…”
Get full text
Journal Article -
9
Olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer at a single institution: A retrospective study
Published in The journal of obstetrics and gynaecology research (01-07-2024)“…Aim In this study, we aimed to investigate patient characteristics, efficacy, prognostic factors, and safety of olaparib maintenance therapy for…”
Get full text
Journal Article -
10
A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis
Published in Gynecologic oncology (01-09-2018)“…Chemotherapy for advanced or recurrent endometrial cancer requires further development. Irinotecan hydrochloride (CPT-11) suppresses tumor growth in several…”
Get full text
Journal Article -
11
Clinical Utility of Endometrial Cell Block Cytology in Postmenopausal Women
Published in Acta cytologica (2017)“…Objective: To investigate the diagnostic utility of endometrial (EM) cell block (CB) cytology for the detection of intrauterine malignancy in postmenopausal…”
Get full text
Journal Article -
12
Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females
Published in Experimental and therapeutic medicine (01-04-2017)“…Currently prophylactic HPV16/18 L1 virus-like particle (VLP) vaccines are employed with great success for the prevention of HPV infection. However, limited…”
Get full text
Journal Article -
13